Standard Biotools (LAB) Receivables (2016 - 2025)
Historic Receivables for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $13.9 million.
- Standard Biotools' Receivables fell 6057.11% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.9 million, marking a year-over-year decrease of 6057.11%. This contributed to the annual value of $15.0 million for FY2024, which is 2488.98% down from last year.
- According to the latest figures from Q3 2025, Standard Biotools' Receivables is $13.9 million, which was down 6057.11% from $15.0 million recorded in Q2 2025.
- Standard Biotools' Receivables' 5-year high stood at $36.0 million during Q1 2024, with a 5-year trough of $10.9 million in Q2 2022.
- Its 5-year average for Receivables is $19.9 million, with a median of $17.3 million in 2022.
- As far as peak fluctuations go, Standard Biotools' Receivables skyrocketed by 14829.01% in 2024, and later crashed by 6057.11% in 2025.
- Quarter analysis of 5 years shows Standard Biotools' Receivables stood at $18.3 million in 2021, then fell by 5.68% to $17.3 million in 2022, then grew by 15.58% to $20.0 million in 2023, then decreased by 24.89% to $15.0 million in 2024, then dropped by 7.12% to $13.9 million in 2025.
- Its Receivables was $13.9 million in Q3 2025, compared to $15.0 million in Q2 2025 and $35.5 million in Q1 2025.